DRYBROOK SURGERY — All Prescriptions & Medications — Page 2
Practice Code: L84024 | DRYBROOK, GL17 9JE
Showing results 51-100 of 472
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Finasteride | 575 | 13.0K | £472 | -12.2% ▼ |
| Spironolactone | 550 | 10.8K | £2.1K | +2.0% ▲ |
| Edoxaban | 546 | 10.4K | £17.3K | -22.1% ▼ |
| Alendronic acid | 521 | 2,088 | £491 | -30.5% ▼ |
| Venlafaxine | 507 | 20.7K | £2.5K | -40.0% ▼ |
| Indapamide | 497 | 12.1K | £522 | -42.4% ▼ |
| Isosorbide mononitrate | 496 | 10.7K | £1.3K | -25.0% ▼ |
| Amoxicillin | 490 | 29.3K | £798 | -47.4% ▼ |
| Atenolol | 489 | 13.2K | £293 | -18.9% ▼ |
| Estradiol | 482 | 37.3K | £6.4K | -41.3% ▼ |
| Tramadol hydrochloride | 470 | 38.0K | £1.6K | -34.4% ▼ |
| Thiamine hydrochloride | 459 | 11.9K | £345 | -12.9% ▼ |
| Glucose blood testing reagents | 442 | 40.7K | £6.3K | -44.0% ▼ |
| Apixaban | 427 | 18.1K | £1.6K | -67.8% ▼ |
| Lercanidipine hydrochloride | 423 | 11.9K | £1.1K | -31.5% ▼ |
| Naproxen | 417 | 23.0K | £854 | -57.8% ▼ |
| Pravastatin sodium | 415 | 5,825 | £301 | +27.8% ▲ |
| Montelukast | 410 | 10.4K | £488 | -40.1% ▼ |
| Rosuvastatin calcium | 409 | 10.4K | £661 | -54.4% ▼ |
| Sildenafil (Erectile Dysfunction) | 401 | 2,348 | £322 | -20.4% ▼ |
| Cetirizine hydrochloride | 386 | 18.9K | £722 | -22.7% ▼ |
| Gabapentin | 381 | 56.5K | £5.1K | -61.8% ▼ |
| Buprenorphine | 372 | 1,684 | £8.9K | +1.5% vs avg |
| Gliclazide | 372 | 14.0K | £422 | -56.3% ▼ |
| Insulin glargine | 363 | 1,791 | £13.8K | +27.9% ▲ |
| Lamotrigine | 359 | 12.8K | £670 | -39.2% ▼ |
| Budesonide | 358 | 1,983 | £11.4K | -33.9% ▼ |
| Estradiol with progestogen | 344 | 16.2K | £9.4K | +0.9% vs avg |
| 339 | 180.0K | £1.4K | -65.6% ▼ | |
| Nitrofurantoin | 316 | 4,888 | £2.6K | -33.8% ▼ |
| Senna | 313 | 14.9K | £364 | -48.0% ▼ |
| Melatonin | 313 | 11.5K | £6.4K | -5.9% ▼ |
| Warfarin sodium | 312 | 11.6K | £426 | -33.8% ▼ |
| 309 | 638 | £21.9K | -43.3% ▼ | |
| Famotidine | 305 | 10.8K | £6.5K | -37.5% ▼ |
| Ferrous sulfate | 305 | 8,338 | £277 | -40.7% ▼ |
| Ezetimibe | 301 | 7,042 | £1.2K | -57.7% ▼ |
| Carbocisteine | 298 | 30.9K | £1.4K | -44.2% ▼ |
| Diltiazem hydrochloride | 282 | 9,117 | £1.7K | -8.2% ▼ |
| Fluticasone/umeclidinium/vilanterol | 282 | 282 | £11.9K | +20.3% ▲ |
| Levetiracetam | 279 | 41.3K | £3.7K | -39.1% ▼ |
| Fexofenadine hydrochloride | 278 | 10.7K | £559 | -67.3% ▼ |
| Escitalopram | 272 | 8,435 | £482 | -4.4% ▼ |
| Desogestrel | 267 | 33.3K | £977 | -32.6% ▼ |
| Memantine hydrochloride | 251 | 7,383 | £2.0K | -24.0% ▼ |
| 247 | 3,120 | £1.9K | -62.8% ▼ | |
| Solifenacin | 242 | 6,316 | £238 | -49.3% ▼ |
| Bisacodyl | 234 | 10.2K | £506 | +78.5% ▲ |
| 232 | 232 | £10.3K | -25.3% ▼ | |
| Insulin aspart | 231 | 1,494 | £8.9K | -39.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.